UGI (NYSE: UGI) CLO exercises options then sells 25,360 shares

Rhea-AI Filing Summary

UGI Corporation’s General Counsel and Chief Legal Officer, Kathleen Shea-Ballay, exercised options to acquire 25,360 shares of UGI common stock at $24.60 per share, then sold the same 25,360 shares in an open-market sale.

The sale was executed at an average price of $33.6157 per share, with individual trades ranging from $33.58 to $33.89. Following these transactions, she holds no UGI common stock directly but retains options for 12,680 shares at a $24.60 exercise price, expiring on December 31, 2033.

Insider Trade Summary

Net Seller: 25,360 shares ($852,494)

Net Sell 3 txns

Insider Shea-Ballay Kathleen

Role GC and Chief Legal Officer

Sold 25,360 shs ($852K)

Type	Security	Shares	Price	Value
Exercise	Options (Right to Buy)	25,360	$0.00	--
Exercise	UGI Common Stock	25,360	$24.60	$624K
Sale	UGI Common Stock	25,360	$33.6157	$852K

Holdings After Transaction: Options (Right to Buy) — 12,680 shares (Direct, null); UGI Common Stock — 25,360 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Shares sold: 25,360 shares Average sale price: $33.6157 per share Options exercised: 25,360 shares at $24.60 +3 more

6 metrics

Shares sold 25,360 shares Open-market sale of UGI common stock on June 18, 2026

Average sale price $33.6157 per share UGI common stock sale price range $33.58–$33.89

Options exercised 25,360 shares at $24.60 Exercise of options into UGI common stock

Options remaining 12,680 options Options to buy UGI common stock after transaction

Option expiration December 31, 2033 Expiration date of remaining UGI stock options

Direct common stock held after 0 shares UGI common stock directly owned post-transaction

Key Terms

open-market sale, derivative exercise/conversion, Options (Right to Buy), exercise price, +1 more

5 terms

open-market sale financial

"transaction_action": "open-market sale"

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

derivative exercise/conversion financial

"transaction_action": "derivative exercise/conversion"

Options (Right to Buy) financial

"security_title": "Options (Right to Buy)"

exercise price financial

"conversion_or_exercise_price": "24.6000"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

Form 4 regulatory

"INSIDER FILING DATA (Form 4)"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Shea-Ballay Kathleen

(Last) (First) (Middle)

500 NORTH GULPH ROAD

(Street)

KING OF PRUSSIA PENNSYLVANIA 19406

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
UGI CORP /PA/ [ UGI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	GC and Chief Legal Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
UGI Common Stock	06/18/2026		M		25,360	A	$24.6	25,360	D
UGI Common Stock	06/18/2026		S		25,360	D	$33.6157(1)	0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Options (Right to Buy)	$24.6	06/18/2026		M			25,360	01/01/2025	12/31/2033	UGI Common Stock	25,360	$0	12,680	D

Explanation of Responses:

1. The shares of common stock with respect to this transaction were purchased at prices ranging from $33.58 and $33.89. Upon request, UGI Corporation will provide to the U.S. Securities and Exchange Commission staff, or a security holder of UGI Corporation, full information regarding the number of shares of common stock purchased at each separate price.

	/s/ Pamela A. Meredith, Attorney-in-Fact for Kathleen Shea-Ballay	06/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did UGI (UGI) report for Kathleen Shea-Ballay?

UGI reported that General Counsel and Chief Legal Officer Kathleen Shea-Ballay exercised options for 25,360 UGI common shares and then sold all 25,360 shares in an open-market transaction, according to a Form 4 insider trading report filed with regulators.

How many UGI shares did Kathleen Shea-Ballay sell in the latest Form 4?

Kathleen Shea-Ballay sold 25,360 shares of UGI common stock. These shares were sold in an open-market transaction after she exercised options for the same number of shares, resulting in no remaining directly held common stock after the sale.

At what prices were Kathleen Shea-Ballay’s UGI shares sold?

Her UGI shares were sold at an average price of $33.6157 per share. A footnote explains that actual sale prices ranged between $33.58 and $33.89, with full trade-by-trade details available from UGI Corporation upon request.

What option exercise did Kathleen Shea-Ballay report for UGI stock?

She reported exercising options to buy 25,360 shares of UGI common stock at a $24.60 exercise price. This derivative exercise converted option holdings into common shares, which were then sold in the open market on the same reported date.

How many UGI stock options does Kathleen Shea-Ballay still hold after this transaction?

After the reported transactions, Kathleen Shea-Ballay retains options covering 12,680 shares of UGI common stock. These remaining options carry a $24.60 exercise price and are scheduled to expire on December 31, 2033, based on the Form 4 disclosure.

Does Kathleen Shea-Ballay still directly own UGI common stock after the sale?

Following the exercise and sale, Kathleen Shea-Ballay directly holds no UGI common stock. The Form 4 shows zero shares of common stock owned directly after the transaction, while she continues to hold a residual position through outstanding stock options.